Foundayo vs Oral Wegovy vs Compounded Oral GLP-1: How All 3 Options Compare
For the first time, patients who want to avoid needles have three distinct oral GLP-1 pathways — two FDA-approved medications and a growing market of compounded alternatives. Each comes with different tradeoffs in price, convenience, efficacy data, and regulatory certainty.
The Head-to-Head Comparison
| Feature | Foundayo | Oral Wegovy | Compounded Oral |
|---|---|---|---|
| Active ingredient | Orforglipron | Semaglutide | Semaglutide or Tirzepatide |
| FDA approved | Yes (Apr 2026) | Yes (Dec 2025) | No |
| Mechanism | GLP-1 only | GLP-1 only | GLP-1 (sema) or GLP-1/GIP (tirz) |
| Food restrictions | None | 30-min fast required | Varies by format |
| Starting price | ~$149+ | $149/mo | $99–$179/mo |
| Maintenance price | Up to $399 | $199–$299/mo | $147–$299/mo |
| Dosing | Once daily | Once daily | Once or twice daily |
| Weight loss data | 12.4% (trials) | ~15% (injectable equiv.) | Limited oral data |
| Molecule type | Small molecule | Peptide (SNAC) | Peptide (various) |
Foundayo: The Convenience Winner
Foundayo's headline advantage is practical: you can take it any time of day, with or without food, with no water restrictions. That's a genuine daily-life upgrade over oral Wegovy's 30-minute fasting requirement. For people with irregular schedules, morning routines that can't accommodate a fasting window, or who simply want the simplest possible protocol — Foundayo wins on convenience.
The tradeoff: Foundayo is a GLP-1-only agonist, and clinical trials showed 12.4% average weight loss at the highest dose — meaningful, but lower than injectable semaglutide's ~15% or injectable tirzepatide's ~22%. It's also a brand-new molecule with a shorter real-world track record.
Oral Wegovy: The Proven Molecule
Oral Wegovy delivers semaglutide — the most studied GLP-1 receptor agonist in history — in pill form using SNAC absorption technology. If you trust semaglutide's clinical data (and there's a mountain of it), oral Wegovy gives you that proven molecule without the injection.
The tradeoffs: the 30-minute empty-stomach requirement is a genuine hassle, and maintenance doses at $199–$299/month are more expensive than some compounded alternatives. Some patients also report that the oral formulation has a different GI side-effect profile than the injectable.
Compounded Oral GLP-1: The Price Leader
Compounded oral GLP-1 medications from telehealth providers start as low as $99/month — significantly cheaper than either FDA-approved option. They also offer more format variety (drops, tablets, gummies, capsules) and the ability to get compounded tirzepatide orally, which neither FDA-approved oral option provides.
The tradeoffs: these are not FDA-approved, the absorption data for sublingual/buccal delivery is limited, and the regulatory environment for compounded GLP-1s is tightening. Patients should understand they're getting a less clinically validated product at a lower price point.
Which One Should You Choose?
Choose Foundayo if: Convenience is your top priority. No food restrictions, no fasting windows, no complicated timing. You want an FDA-approved medication with a simple daily routine.
Choose oral Wegovy if: You want the most clinically studied GLP-1 molecule in oral form. You're comfortable with the 30-minute fasting requirement. You may already be on injectable Wegovy and want to switch to the pill.
Choose compounded oral GLP-1 if: Price is the deciding factor. You want oral tirzepatide (not available FDA-approved). You prefer a specific format (gummies, drops, capsules). You understand and accept the regulatory and clinical-data limitations.